BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31783899)

  • 1. Association between pain phenotype and disease activity in rheumatoid arthritis patients: a non-interventional, longitudinal cohort study.
    Ten Klooster PM; de Graaf N; Vonkeman HE
    Arthritis Res Ther; 2019 Nov; 21(1):257. PubMed ID: 31783899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can the painDETECT Questionnaire score and MRI help predict treatment outcome in rheumatoid arthritis: protocol for the Frederiksberg hospital's Rheumatoid Arthritis, pain assessment and Medical Evaluation (FRAME-cohort) study.
    Rifbjerg-Madsen S; Christensen AW; Boesen M; Christensen R; Danneskiold-Samsøe B; Bliddal H; Bartels EM; Locht H; Amris K
    BMJ Open; 2014 Nov; 4(11):e006058. PubMed ID: 25394817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis.
    Salaffi F; Gerardi MC; Atzeni F; Batticciotto A; Talotta R; Draghessi A; Di Carlo M; Sarzi-Puttini P
    Rheumatol Int; 2017 Dec; 37(12):2035-2042. PubMed ID: 28875224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The subjective components of the Disease Activity Score 28-joints (DAS28) in rheumatoid arthritis patients and coexisting fibromyalgia.
    Salaffi F; Di Carlo M; Carotti M; Sarzi-Puttini P
    Rheumatol Int; 2018 Oct; 38(10):1911-1918. PubMed ID: 29955927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis.
    Ranzolin A; Brenol JC; Bredemeier M; Guarienti J; Rizzatti M; Feldman D; Xavier RM
    Arthritis Rheum; 2009 Jun; 61(6):794-800. PubMed ID: 19479706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study.
    Sokka T; Toloza S; Cutolo M; Kautiainen H; Makinen H; Gogus F; Skakic V; Badsha H; Peets T; Baranauskaite A; Géher P; Ujfalussy I; Skopouli FN; Mavrommati M; Alten R; Pohl C; Sibilia J; Stancati A; Salaffi F; Romanowski W; Zarowny-Wierzbinska D; Henrohn D; Bresnihan B; Minnock P; Knudsen LS; Jacobs JW; Calvo-Alen J; Lazovskis J; Pinheiro Gda R; Karateev D; Andersone D; Rexhepi S; Yazici Y; Pincus T;
    Arthritis Res Ther; 2009; 11(1):R7. PubMed ID: 19144159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced treatment strategies and distinct disease outcomes among autoantibody-positive and -negative rheumatoid arthritis patients over 25 years: A longitudinal cohort study in the Netherlands.
    Matthijssen XME; Niemantsverdriet E; Huizinga TWJ; van der Helm-van Mil AHM
    PLoS Med; 2020 Sep; 17(9):e1003296. PubMed ID: 32960885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.
    Shadick NA; Gerlanc NM; Frits ML; Stolshek BS; Brady BL; Iannaccone C; Collier D; Cui J; Mutebi A; Weinblatt ME
    Clin Rheumatol; 2019 Nov; 38(11):3081-3092. PubMed ID: 31353421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis.
    Tanaka Y; Smolen JS; Jones H; Szumski A; Marshall L; Emery P
    Arthritis Res Ther; 2019 Jul; 21(1):164. PubMed ID: 31277720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice.
    Boone NW; Sepriano A; van der Kuy PH; Janknegt R; Peeters R; Landewé RBM
    RMD Open; 2019; 5(2):e001050. PubMed ID: 31908842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiographic progression can still occur in individual patients with low or moderate disease activity in the current treat-to-target paradigm: real-world data from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.
    Ten Klooster PM; Versteeg LGA; Oude Voshaar MAH; de la Torre I; De Leonardis F; Fakhouri W; Zaremba-Pechmann L; van de Laar M
    Arthritis Res Ther; 2019 Nov; 21(1):237. PubMed ID: 31718678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic widespread pain in patients with rheumatoid arthritis and the relation between pain and disease activity measures over the first 5 years.
    Andersson ML; Svensson B; Bergman S
    J Rheumatol; 2013 Dec; 40(12):1977-85. PubMed ID: 24187108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis.
    Sandberg ME; Bengtsson C; Källberg H; Wesley A; Klareskog L; Alfredsson L; Saevarsdottir S
    Ann Rheum Dis; 2014 Nov; 73(11):2029-33. PubMed ID: 24818635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The course of pain hypersensitivity according to painDETECT in patients with rheumatoid arthritis initiating treatment: results from the prospective FRAME-cohort study.
    Rifbjerg-Madsen S; Christensen AW; Boesen M; Christensen R; Danneskiold-Samsøe B; Bliddal H; Dreyer L; Locht H; Amris K
    Arthritis Res Ther; 2018 May; 20(1):105. PubMed ID: 29848348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort.
    Vermeer M; Kuper HH; Bernelot Moens HJ; Hoekstra M; Posthumus MD; van Riel PL; van de Laar MA
    Arthritis Res Ther; 2012 Nov; 14(6):R254. PubMed ID: 23176083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised controlled trial of tumour necrosis factor inhibitors against combination intensive therapy with conventional disease-modifying antirheumatic drugs in established rheumatoid arthritis: the TACIT trial and associated systematic reviews.
    Scott DL; Ibrahim F; Farewell V; O'Keeffe AG; Ma M; Walker D; Heslin M; Patel A; Kingsley G
    Health Technol Assess; 2014 Oct; 18(66):i-xxiv, 1-164. PubMed ID: 25351370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of change in bodily pain in early rheumatoid arthritis: an inception cohort study.
    McWilliams DF; Zhang W; Mansell JS; Kiely PD; Young A; Walsh DA
    Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1505-13. PubMed ID: 22556121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial.
    Smolen JS; Szumski A; Koenig AS; Jones TV; Marshall L
    Arthritis Res Ther; 2018 Jan; 20(1):8. PubMed ID: 29338762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain and pain mechanisms in patients with inflammatory arthritis: A Danish nationwide cross-sectional DANBIO registry survey.
    Rifbjerg-Madsen S; Christensen AW; Christensen R; Hetland ML; Bliddal H; Kristensen LE; Danneskiold-Samsøe B; Amris K
    PLoS One; 2017; 12(7):e0180014. PubMed ID: 28686639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease progression and treatment responses in a prospective DMARD-naive seropositive early rheumatoid arthritis cohort: does gender matter?
    Jawaheer D; Maranian P; Park G; Lahiff M; Amjadi SS; Paulus HE
    J Rheumatol; 2010 Dec; 37(12):2475-85. PubMed ID: 20889597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.